Pacira BioSciences (PCRX) Other Accumulated Expenses (2011 - 2012)
Pacira BioSciences' (PCRX) quarterly Other Accumulated Expenses came in at $360000.0 in Q4 2012, up 4.35% year-on-year from $345000.0 in Q1 2012, and up 4.35% quarter-over-quarter from $345000.0 in Q4 2011.
Pacira BioSciences (PCRX) Other Accumulated Expenses (2011 - 2012) Analysis & Trends
Pacira BioSciences' Other Accumulated Expenses history runs 2 years deep, the most recent figure standing at $360000.0 for Q4 2012.
- On a quarterly basis, Other Accumulated Expenses rose 4.35% year-over-year to $360000.0 in Q4 2012; TTM through Dec 2012 was $360000.0, a 4.35% increase from a year earlier, with the FY2012 full-year figure at $360000.0, up 4.35% from the prior year.
- Other Accumulated Expenses rose to $360000.0 in Q4 2012 per PCRX's latest filing, from $345000.0 in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $360000.0 in Q4 2012 and bottomed at $345000.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn |
| 10 | Pacira BioSciences | 1.07 Bn | 863.97 Mn | 140.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2012 | 360,000.00 |
| Dec 31, 2011 | 345,000.00 |